Results 21 to 30 of about 62,886 (320)

Clinical characteristics and risk factors for cefaclor-induced immediate hypersensitivity: a retrospective observation at two university hospitals in Korea

open access: yesAllergy, Asthma & Clinical Immunology, 2021
Background Cefaclor, a second-generation oral cephalosporin, is widely prescribed to treat infectious diseases. Immediate hypersensitivity (HS) reactions to cefaclor have continuously been reported and are expected to increase with its greater use.
Hyo-In Rhyou   +8 more
doaj   +1 more source

Bayesian model selection in logistic regression for the detection of adverse drug reactions [PDF]

open access: yes, 2015
Motivation: Spontaneous adverse event reports have a high potential for detecting adverse drug reactions. However, due to their dimension, exploring such databases requires statistical methods.
Marbac, Matthieu   +2 more
core   +2 more sources

Correction to: Regulatory, scientific, and ethical issues arising from institutional activity in one of the 90 Italian Research Ethics Committees

open access: yesBMC Medical Ethics, 2021
An amendment to this paper has been published and can be accessed via the original article.
G. Benfatto   +3 more
doaj   +1 more source

Pharmacovigilance of Biosimilars [PDF]

open access: yes, 2013
In lieu of an abstract, here is the article\u27s first paragraph: Biotech industry forms the backbone of the current pharmaceutical products. Seven out of top ten anticipated drugs of the industry in 2014 will be biologics [1].
Chablani, Lipika
core   +2 more sources

Safety and Effectiveness of Molnupiravir (LAGEVRIO®) Capsules in Japanese Patients with COVID-19: Interim Report of Post-marketing Surveillance in Japan

open access: yesInfectious Diseases and Therapy, 2023
Introduction Molnupiravir is an oral antiviral drug that received special approval for emergency use in Japan on December 24 2021 for infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Masahiro Kimata   +4 more
doaj   +1 more source

Adverse Effects of Cholinesterase Inhibitors in Dementia, According to the Pharmacovigilance Databases of the United-States and Canada. [PDF]

open access: yes, 2015
This survey analyzes two national pharmacovigilance databases in order to determine the major adverse reactions observed with the use of cholinesterase inhibitors in dementia.
Abagyan, Ruben   +4 more
core   +3 more sources

Social media mining for identification and exploration of health-related information from pregnant women [PDF]

open access: yes, 1989
Widespread use of social media has led to the generation of substantial amounts of information about individuals, including health-related information.
Chandrashekar, Pramod Bharadwaj   +3 more
core   +8 more sources

An evaluation of postmarketing reports of hyperglycaemia associated with dolutegravir for treatment of HIV in Eswatini

open access: yesAIDS Research and Therapy, 2022
Background Dolutegravir (DTG) is an Integrase Strand Transfer Inhibitor (INSTI) indicated in combination with other antiretroviral agents for the treatment of HIV infection.
Alemayehu L. Duga   +5 more
doaj   +1 more source

Linked health data for pharmacovigilance in children : Perceived legal and ethical issues for stakeholders and data guardians [PDF]

open access: yes, 2014
Peer reviewedPublisher ...
Bond, Christine M   +4 more
core   +2 more sources

Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology [PDF]

open access: yesInternational Journal of Clinical Pharmacy, 2018
AbstractThe terminology used in pharmacovigilance can cause confusion, because there are similar terms that describe different phenomena (e.g. adverse reactions, adverse drug reactions, and side effects). Incorrect use of terminology can have negative effects on the reporting of adverse drug reactions and on the interpretation of these reports.
Paolo Baldo   +2 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy